Immediate Impact

1 by Nobel laureates 3 from Science/Nature 55 standout
Sub-graph 1 of 25

Citing Papers

The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Inhalable nanovesicles loaded with a STING agonist enhance CAR-T cell activity against solid tumors in the lung
2025 Standout
2 intermediate papers

Works of Toshifumi Doi being referenced

The JAK/STAT pathway is involved in the upregulation of PD-L1 expression in pancreatic cancer cell lines
2017
Cytotoxic T lymphocyte-associated antigen 4 inhibition increases the antitumor activity of adoptive T-cell therapy when carried out with naïve rather than differentiated T cells
2015

Author Peers

Author Last Decade Papers Cites
Toshifumi Doi 277 163 292 186 58 769
Boram Han 327 157 333 235 56 853
Seung‐Hoon Beom 444 219 348 145 68 847
Laura Visa 476 242 320 136 36 745
Edoardo Troncone 259 358 288 219 59 849
Sang Byung Bae 374 142 193 313 67 873
Itaru Omoto 327 232 255 220 48 786
Yeng Ang 151 408 202 209 49 956
Pieter Dewint 200 260 216 113 44 976
Fadi Farhat 194 134 231 184 55 669
Juliana Andrici 303 276 377 161 33 965

All Works

Loading papers...

Rankless by CCL
2026